Pregled bibliografske jedinice broj: 97955
Terbinafine in tinea capitis: Overview of efficacy and safety from randomized double-blind duration-finding trials
Terbinafine in tinea capitis: Overview of efficacy and safety from randomized double-blind duration-finding trials // European Journal of Pediatric Dermatology (English Ed.), 11 (2001) (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)
CROSBI ID: 97955 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Terbinafine in tinea capitis: Overview of efficacy and safety from randomized double-blind duration-finding trials
Autori
Friedlander, S.F. ; Skerlev, M. ; Lipozenčić, J. ; Aly, R. ; Krafchik, B. ; Honig, P. ; Gupta, A.K. ; Wraith, L.A. ; Gourmala, N.G. ; Abrams, B. ; Paul, C.
Izvornik
European Journal of Pediatric Dermatology (English Ed.) (1122-7672) 11
(2001);
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, znanstveni
Ključne riječi
tinea capitis; terbinafine; Microsporum canis
Sažetak
Terbinafine, a fungicidal agent against dermatophytes, has the ability to concentrate in hair, nail and skin. Two multicentre, double-blind, duration-finding studies in tinea capitis, investigating the efficacy and safety of terbinafine were recently completed. Thesae two studies constitue the largest randomised double-blind trials performed in the indication tinea capitis. Oral terbinafine was well tolerated and showed good efficacy in tinea capitis caused by both Trichophyton and Microsporum species.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
